SE9203298D0 - Laekemedel med antidopamineffekt - Google Patents

Laekemedel med antidopamineffekt

Info

Publication number
SE9203298D0
SE9203298D0 SE9203298A SE9203298A SE9203298D0 SE 9203298 D0 SE9203298 D0 SE 9203298D0 SE 9203298 A SE9203298 A SE 9203298A SE 9203298 A SE9203298 A SE 9203298A SE 9203298 D0 SE9203298 D0 SE 9203298D0
Authority
SE
Sweden
Prior art keywords
antidopamine
medicinal product
effect medicinal
effect
product
Prior art date
Application number
SE9203298A
Other languages
English (en)
Inventor
Herbert Schwind
Original Assignee
Herbert Schwind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbert Schwind filed Critical Herbert Schwind
Priority to SE9203298A priority Critical patent/SE9203298D0/sv
Publication of SE9203298D0 publication Critical patent/SE9203298D0/sv

Links

SE9203298A 1992-11-05 1992-11-05 Laekemedel med antidopamineffekt SE9203298D0 (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE9203298A SE9203298D0 (sv) 1992-11-05 1992-11-05 Laekemedel med antidopamineffekt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9203298A SE9203298D0 (sv) 1992-11-05 1992-11-05 Laekemedel med antidopamineffekt

Publications (1)

Publication Number Publication Date
SE9203298D0 true SE9203298D0 (sv) 1992-11-05

Family

ID=20387712

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9203298A SE9203298D0 (sv) 1992-11-05 1992-11-05 Laekemedel med antidopamineffekt

Country Status (1)

Country Link
SE (1) SE9203298D0 (sv)

Similar Documents

Publication Publication Date Title
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
FI930882A (fi) Farmaceutiska foereningar
FI954402A0 (sv) Ny farmaceutisk produkt
NO942923L (no) Medikamenter
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
NO930543L (no) Doseringsform
NO931831D0 (no) Farmasoeytiske blandinger
FI935065A0 (fi) Farmaceutiska foereningar
FI931251A0 (fi) Farmaceutiska foereningar
DK86492D0 (da) Laegemiddel
FI921786A (fi) Farmaceutisk foerening
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI921785A (fi) Farmaceutisk foerening
FI930922A0 (fi) Substituerade fenylkinazolinderivat
FI912947A0 (sv) Produktunderlag
SE9203298D0 (sv) Laekemedel med antidopamineffekt
ITMI912652A0 (it) Medicamento ad attivita' antielasica
SE9102577D0 (sv) Laekemedel med antidopamineffekt
SE9003275D0 (sv) Laekemedel med antidopamineffekt
SE9000231D0 (sv) Laekemedel med antidopamineffekt
DK137192D0 (da) Laegemiddel/-plante
UA25976C2 (uk) Противиразковий лікарський препарат